Business Context and Reporting Period
This Form 8-K Current Report was filed by My Size, Inc. on July 6, 2022, with the earliest event reported on the same date. The Company, incorporated in Delaware and headquartered in Israel, operates on the Nasdaq Capital Market under the trading symbol MYSZ. The filing primarily addresses regulatory compliance regarding the Company's stock listing status.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on corporate governance and listing status events.
Material Changes and Events
- Nasdaq Listing Extension: On July 6, 2022, the Company received notice from Nasdaq granting an additional 180-day period to regain compliance with the minimum $1.00 bid price per share requirement.
- Compliance Deadline: The new deadline to demonstrate compliance is January 2, 2023.
- Delisting Risk: If the Company fails to meet the bid price requirement by the January 2, 2023 deadline, Nasdaq will issue written notification of delisting.
- Appeal Rights: In the event of a delisting notification, the Company retains the right to appeal the determination to a Hearings Panel.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future operations, or specific risk factors beyond the immediate threat of delisting. The primary contingency identified is the potential removal of the Company's common stock from the Nasdaq Capital Market if the minimum bid price is not sustained by the extended deadline.
Investor Verification Checklist
- Verify the current trading price of MYSZ to assess the likelihood of meeting the $1.00 bid price requirement by January 2, 2023.
- Review the press release dated July 7, 2022 (Exhibit 99.1) for any additional details on the Company's plan to regain compliance.
- Monitor future 8-K filings for updates on the Company's compliance status or any formal delisting notices from Nasdaq.
- Check the Company's most recent 10-K or 10-Q filings for underlying financial performance that may impact stock price recovery.